USMLE Step 2 CK practice question: High-risk febrile neutropenia after AML induction: empiric IV cefepime within 1 hour

USMLE Step 2 CKHematology/OncologyInternal Medicine

A 58-year-old man with acute myeloid leukemia develops a temperature of 38.7°C (101.7°F) on day 11 after induction chemotherapy. He reports chills but no cough, dysuria, diarrhea, or abdominal pain. Pulse is 106/min, blood pressure is 124/76 mm Hg, respirations are 18/min, and oxygen saturation is 97% on room air. The skin over his implanted port is not red or tender. The lungs are clear, the oral mucosa is intact, and the abdomen is soft and nontender. Leukocyte count is 400/mm³, with an absolute neutrophil count of 60/mm³. Blood cultures have been drawn from the port and a peripheral vein, and urine has been sent for culture. Chest radiograph is normal.

Which of the following is the most appropriate empiric antimicrobial therapy?

  1. Oral ciprofloxacin plus amoxicillin-clavulanate as an outpatient
  2. IV ceftriaxone monotherapy
  3. IV cefepime monotherapy
  4. IV vancomycin plus micafungin
  5. No antibiotics until blood cultures grow an organism
Show answer and explanation

Correct answer: C. IV cefepime monotherapy

Fever (a single oral temperature of 38.3°C [101°F] or higher, or 38.0°C [100.4°F] or higher sustained for 1 hour) with an absolute neutrophil count below 500/mm³, or expected to fall below 500/mm³ within 48 hours, is febrile neutropenia, a medical emergency. This patient is high risk: profound neutropenia (100/mm³ or less) that is expected to last more than 7 days after AML induction. High-risk patients are admitted and given empiric IV monotherapy with an antipseudomonal beta-lactam, such as cefepime, piperacillin-tazobactam, or a carbapenem (meropenem), within 60 minutes of presentation, after blood cultures are drawn but without waiting for results. Neutropenic patients may show few signs of infection, and gram-negative bacteremia, especially with Pseudomonas aeruginosa, can progress to septic shock within hours.

Vancomycin is not routine; it is added for hemodynamic instability, suspected catheter-related infection, skin or soft-tissue infection, pneumonia, known MRSA colonization, or severe mucositis in a patient on fluoroquinolone prophylaxis. Empiric antifungal therapy is considered for fever that persists 4 to 7 days despite antibiotics. Low-risk patients (for example, a MASCC score of 21 or higher and a short expected duration of neutropenia) may be treated with oral ciprofloxacin plus amoxicillin-clavulanate.

Why the other options are wrong

  • A. Oral ciprofloxacin plus amoxicillin-clavulanate as an outpatient — Oral outpatient therapy is limited to low-risk patients; profound, prolonged neutropenia after AML induction is high risk.
  • B. IV ceftriaxone monotherapy — Ceftriaxone lacks reliable activity against Pseudomonas aeruginosa, a key pathogen to cover in febrile neutropenia.
  • D. IV vancomycin plus micafungin — This combination lacks gram-negative coverage; vancomycin is added only for specific indications, and antifungals for persistent fever.
  • E. No antibiotics until blood cultures grow an organism — Delaying antibiotics until cultures turn positive increases mortality; empiric therapy must start within 60 minutes.

Key point

High-risk febrile neutropenia requires empiric IV antipseudomonal beta-lactam monotherapy, such as cefepime, within 1 hour of presentation.

Memory hook

Neutropenic fever is a 60-minute emergency: cultures, then cefepime (or piperacillin-tazobactam or meropenem). Vancomycin needs a specific reason.

Share: Telegram WhatsApp X LinkedIn

Practice like this every day

15 free bank questions a day, exam-length timed blocks, spaced repetition and 3D anatomy — in English and Russian.

Play free

More free questions in this system

Cisplatin toxicity (ototoxicity, nephrotoxicity, hypomagnesemia): DNA cross-linkingUSMLE Step 1 · Hematology/OncologyWarfarin-induced skin necrosis: early protein C depletionUSMLE Step 1 · Hematology/OncologyTumor lysis syndrome: rasburicase mechanism and G6PD deficiencyUSMLE Step 1 · Hematology/Oncology

All free questions →